Tim Meyer

Jan 1, 2025 | bmjopensem.bmj.com | Florian Egger |Ana Ukaj |Tim Meyer

FootballResuscitationAutomatic external defibrillatorDeathSoccerWHAT IS ALREADY KNOWN ON THIS TOPICEmergency response planning for sudden cardiac arrest (SCA) seems sufficient in top-division professional football clubs but tends to be inadequate in lower divisions. WHAT THIS STUDY ADDSEmergency readiness data from a wide range of amateur football clubs at a national level.

Oct 5, 2023 | jamanetwork.com | Shukui Qin |Masatoshi Kudo |Kindai Faculty |Tim Meyer

Key PointsQuestion  How does the efficacy and safety profile of tislelizumab compare with that of sorafenib as first-line treatment among patients with unresectable hepatocellular carcinoma (HCC)? Findings  In this phase 3 randomized clinical trial of 674 patients with HCC, tislelizumab demonstrated overall survival noninferiority compared with sorafenib, with numerically higher and more durable objective responses than sorafenib.